Telehealth Prescribing Flexibilities May be Extended By DEA in Response to Feedback from Stakeholders
The U.S. Drug Enforcement Agency (DEA) will extend telemedicine flexibilities around the prescription of certain controlled medications as it considers stakeholder feedback on proposed rules for post-COVID remote prescribing guardrails. The DEA received over…
Continue Reading